A commonly used assay to determine the ability of PTEN and its mutants to regulate PI3K/AKT signalling involves expression in the PTEN-null U-87 MG glioblastoma cell line (further referred to as U87) and assessment of AKT phosphorylation and cell proliferation (Davidson et al., 2010). This evidence concerns the gene AKT1 and glioblastoma.